Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

NCT06204809 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Dystrophy 1

Interventions

DRUG: PGN-EDODM1 for infusion
OTHER: Placebo

Sponsor

PepGen Inc